Immunotherapy

September 26, 2024

Trial Results: How one patient’s role in an ECOG-ACRIN study for acute lymphocytic leukemia brought a cancer-free diagnosis and FDA approval

Adding immunotherapy to standard chemotherapy keeps most patients with B-cell acute lymphoblastic leukemia in remission and improves their survival
January 22, 2024

Ongoing Trial: The PET-Stop clinical trial is looking to improve the care of patients with advanced melanoma treated with immunotherapy

The study explores whether imaging and tumor biopsy looking for remaining disease can identify melanoma patients who can safely stop immunotherapy treatment early